EXACT Sciences Corporation

06/16/2025 | Press release | Distributed by Public on 06/16/2025 06:01

Proxy Results, Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 12, 2025, the shareholders of Exact Sciences Corporation (the "Company") approved the adoption of the Company's 2025 Omnibus Long-Term Incentive Plan (the "2025 Omnibus Plan") at the 2025 Annual Meeting of Shareholders of the Company (the "2025 Annual Meeting"). A description of the terms and conditions of the 2025 Omnibus Plan is set forth in the Company's Proxy Statement for the 2025 Annual Meeting, as filed with the Securities and Exchange Commission on April 29, 2025 (the "2025 Proxy Statement") under the heading "Proposal 4 - Approval of the 2025 Omnibus Long-Term Incentive Plan," which such description is incorporated by reference herein.
Additionally, at the 2025 Annual Meeting, the Company's shareholders approved an amendment (the "Amendment") to the Company's Amended and Restated 2010 Employee Stock Purchase Plan (as amended and restated on July 31, 2024) (the "Stock Purchase Plan"). A description of the terms and conditions of the Stock Purchase Plan, as amended by the Amendment, is set forth in the 2025 Proxy Statement under the heading "Proposal 5 - Amendment to the 2010 Employee Stock Purchase Plan (as amended and restated on July 31, 2024)", which such description is incorporated by reference herein.
These summaries of the 2025 Omnibus Plan and the Amendment do not purport to be complete and are subject to, and qualified in their entirety by, the full text of the 2025 Omnibus Plan and the Amendment, copies of which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K and are incorporated by reference into this Item 5.02.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 12, 2025, the Company held its 2025 Annual Meeting. The certified results of the matters voted upon at the 2025 Annual Meeting, which are more fully described in the 2025 Proxy Statement, are as follows:
The Company's shareholders elected the seven nominees to the Company's Board of Directors, each to serve for a one-year term expiring at the Company's 2026 annual meeting (each to serve until his or her successor is elected and qualified or until his or her earlier death, resignation or removal), with the votes cast as follows:
Director Name For Against Abstain Broker Non-Votes
Michael Barber 148,719,201 1,637,072 81,547 20,245,017
Paul Clancy 144,697,347 5,662,119 78,354 20,245,017
Daniel Levangie 147,043,069 3,320,750 74,001 20,245,017
Kevin Conroy
146,003,613 3,963,765 470,442 20,245,017
Shacey Petrovic
144,820,162 5,544,465 73,193 20,245,017
Kimberly Popovits
148,693,171 1,670,512 74,137 20,245,017
Katherine Zanotti
145,127,526 5,238,675 71,619 20,245,017
The Company's shareholders ratified the appointment of PricewaterhouseCoopers, LLP as the Company's independent registered public accounting firm for 2025, with votes cast as follows:
For Against Abstain
169,769,642 456,507 456,688
The Company's shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers, with votes cast as follows:
For Against Abstain Broker Non-Votes
140,371,292 9,625,458 441,070 20,245,017
2
The Company's shareholders approved the Company's 2025 Omnibus Long-Term Incentive Plan, with votes cast as follows:
For Against Abstain Broker Non-Votes
144,174,691 5,954,333 308,796 20,245,017
The Company's shareholders approved the Amendment to Company's Amended and Restated 2010 Employee Stock Purchase Plan (as amended and restated on July 31, 2024), with votes cast as follows:
For Against Abstain Broker Non-Votes
148,722,010 1,608,444 107,366 20,245,017
The Company's shareholders did not approve a stockholder proposal concerning the adoption of a director election resignation governance policy, with votes cast as follows:
For Against Abstain Broker Non-Votes
44,298,527 105,715,825 423,468 20,245,017
EXACT Sciences Corporation published this content on June 16, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on June 16, 2025 at 12:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io